Protecting Americans from Unsafe Drugs Act of 2023

Summary

Protecting Americans from Unsafe Drugs Act of 2023 This bill expands the authority of the Secretary of the Department of Health and Human Services (HHS) to order the recall of controlled substances to cover all drugs. Furthermore, the authority to issue such an order may be delegated to the Director of the Center for Drug Evaluation and Research or the Director of the Center for Biologics Evaluation and Research (or an official senior to either director), whereas currently this authority may only be delegated to the Director of the Center for Drug Evaluation and Research or an official senior to such director. (Both centers are located in the Food and Drug Administration within HHS.)

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 6 April 2023

   Introduced

   Referred to the House Committee on Energy and Commerce.

   Source: IntroReferral

2. 6 April 2023

   Introduced

   Introduced in House

   Source: IntroReferral

3. 6 April 2023

   Introduced

   Introduced in House

   Source: IntroReferral

4. 14 April 2023

   Referred

   Referred to the Subcommittee on Health.

   Source: Committee

Votes

No vote records are attached yet.

Versions

• Introduced in House · 6 April 2023 · Official file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 6 April 2023

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 6 April 2023

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 6 April 2023

  Open at official source

Sponsors

• Sen. Kim, Andy [D-NJ] · D · Sponsor
• John Sarbanes · D · Cosponsor
• · hsif00 · Standing

Related records

• related to ← Protecting PAHPA Act of 2023
• related to ← Protecting Americans from Unsafe Drugs Act of 2022